Audit of FDA Inspections of Generics Makers Planned by OIG for 2015

An HHS watchdog will audit how the FDA inspects generics manufacturing facilities, oversees postmarketing studies and ensures compliance with clinical trial reporting requirements, as well as how the drug industry is implementing the track-and-trace law.
Generic Line